Education
About Us
Working with TipRanks
Follow Us
Monash IVF Group Ltd (AU:MVF)
ASX:MVF
MVF Stock Chart & Stats
AU$0.63
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.63
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.54 - AU$1.17
Previous CloseN/A
Volume300.99K
Average Volume (3M)2.18M
Market Cap
AU$245.47M
Enterprise ValueAU$527.28M
Total Cash (Recent Filing)AU$8.14M
Total Debt (Recent Filing)AU$281.81M
Price to Earnings (P/E)10.0
Beta1.20
Next Earnings
Aug 26, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend Yield6.22%
Share Statistics
EPS (TTM)0.02
Shares Outstanding389,634,830
10 Day Avg. Volume1,374,502
30 Day Avg. Volume2,181,726
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.12
Price to Sales (P/S)1.01
P/FCF Ratio588.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.79Price Target Upside25.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$266.46M
Bulls Say, Bears Say
Bulls Say
Profitability MarginsSustained gross margin of 33.2% and net margin of 9.2% indicate the business can capture pricing for clinical and lab services while controlling costs. Durable margins support reinvestment in clinics and labs and provide a buffer through normal demand cycles.
Integrated Clinic And Lab NetworkAn integrated network of clinics and in-house laboratories creates operational synergies, referral stickiness and quality control advantages. This vertical setup raises barriers to entry, supports higher utilisation and offers diversified revenue streams across services and geographies.
Balanced Capital Structure And ROEA moderate debt-to-equity ratio of 0.73 combined with a 10.2% ROE suggests the company uses leverage prudently while generating acceptable returns on shareholder capital. This structural balance supports strategic investment without excessive financial strain.
Bears Say
Free Cash Flow CollapseA near-total decline in free cash flow is a material structural weakness: it limits the company’s ability to self-fund growth, service debt, or sustain distributions. Unless operational or working-capital drivers are fixed, financing flexibility and strategic options are constrained.
Weak Cash ConversionLow operating cash flow relative to net income shows earnings are not converting to cash efficiently, increasing liquidity risk. This persistent conversion gap can force reliance on external funding and undermines the durability of reported profits for reinvestment.
Revenue Exposure To Reimbursement And CapacityRevenue dependence on government reimbursement rules, insurance coverage and clinician availability makes demand sensitive to policy and staffing shifts. Structural exposure to these external levers can create uneven growth and pressure margins over the medium term.
Monash IVF Group Ltd News
MVF FAQ
What was Monash IVF Group Ltd’s price range in the past 12 months?
Monash IVF Group Ltd lowest share price was AU$0.54 and its highest was AU$1.17 in the past 12 months.
What is Monash IVF Group Ltd’s market cap?
Monash IVF Group Ltd’s market cap is AU$245.47M.
When is Monash IVF Group Ltd’s upcoming earnings report date?
Monash IVF Group Ltd’s upcoming earnings report date is Aug 26, 2026 which is in 161 days.
How were Monash IVF Group Ltd’s earnings last quarter?
Monash IVF Group Ltd released its earnings results on Feb 25, 2026. The company reported AU$0.018 earnings per share for the quarter, missing the consensus estimate of AU$0.025 by -AU$0.007.
Is Monash IVF Group Ltd overvalued?
According to Wall Street analysts Monash IVF Group Ltd’s price is currently Undervalued.
Does Monash IVF Group Ltd pay dividends?
Monash IVF Group Ltd pays a Semiannually dividend of AU$0.026 which represents an annual dividend yield of 6.22%. See more information on Monash IVF Group Ltd dividends here
What is Monash IVF Group Ltd’s EPS estimate?
Monash IVF Group Ltd’s EPS estimate is 0.02.
How many shares outstanding does Monash IVF Group Ltd have?
Monash IVF Group Ltd has 389,634,830 shares outstanding.
What happened to Monash IVF Group Ltd’s price movement after its last earnings report?
Monash IVF Group Ltd reported an EPS of AU$0.018 in its last earnings report, missing expectations of AU$0.025. Following the earnings report the stock price went up 2.954%.
Which hedge fund is a major shareholder of Monash IVF Group Ltd?
Currently, no hedge funds are holding shares in AU:MVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Monash IVF Group Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.79 (25.71% Upside)
AU$0.79 (25.71% Upside)
Blogger Sentiment
Bullish
AU:MVF Sentiment 89%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth AU$53.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.39%
12-Months-Change
Fundamentals
Return on Equity
6.06%
Trailing 12-Months
Asset Growth
0.49%
Trailing 12-Months
Company Description
Monash IVF Group Ltd
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. The company was incorporated in 2014 and is based in Richmond, Australia.
MVF Stock 12 Month Forecast
Average Price Target
AU$0.79
▲(25.71% Upside)
Technical Analysis
Healius Limited
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---